Biotech

All Articles

Lilly, Haya ink $1B biobuck weight problems pact to explore dark genome

.Eli Lilly's hunt for being overweight targets has led it to the dark genome. The Big Pharma has act...

ArsenalBio increases $325M, turns far from previous lead possession

.Collection Biosciences is actually proceeding up. The tissue therapy company has actually added on ...

Lilly- backed weight-loss biotech reports IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has filed to ...

Aelis' marijuana make use of drug fails phase 2b, driving Indivior to reassess $100M alternative

.Aelis Farma's hopes of protecting a simple, beneficial selection on a $one hundred million choice r...

ProKidney stops stage 3 test certainly not required for cell therapy approval

.ProKidney has actually quit some of a pair of period 3 trials for its cell treatment for kidney hea...

Vaxcyte rises on 'stunning' 31-valent PCV succeed versus Pfizer

.Vaxcyte revealed what professionals called "spectacular" stage 1/2 data for its own 31-valent pneum...

Recursion's mind condition trial shows insufficient evidence of efficacy

.Recursion has actually discovered by means of a very early examination of its own tech-enabled appr...

Acepodia, Pfizer click on together for chemistry-based tissue therapy

.Call it a case of really good chemistry: Acepodia, a biotech based on Nobel Champion science, is ac...

Praxis epilepsy medication decreases seizures in phase 2 trial

.Practice Precision Medicines has actually racked up yet another midphase succeed in epilepsy this y...

Three directors surrender as Dyne messages combined information for DMD prospect

.After getting away from a clinical grip many years back, Dyne Therapy has uncovered brand new stage...